New York, NY, July 21, 2024 - Kainjoo Inc, a US subsidiary of the Swiss-based Kainjoo Group, is proud to announce the establishment of its new office in New York City, marking a significant milestone in the company’s global expansion strategy. This move aims to enhance our presence in North America and structure our market operations overseas. Kainjoo Inc., renowned for its expertise in programmatic advertising and deep knowledge of regulated industries, is now operational in New York. The company is rapidly expanding its reach to the Florida states, leveraging its robust network of partners and clients.

• Trusted by Industry Leaders: Kainjoo Inc. has built a reputation for excellence and is trusted by leading companies such as Ferring Pharmaceuticals, Thermo Fisher, Abbott, and Medtronic.
• Managing Allegory Capital’s $50M 2k32 Fund: Kainjoo is the management company for Allegory Capital’s $50M fund, designed to support regulated industries in acquiring or investing in tech ventures.
• Expanding Footprint in North America: Kainjoo Inc.’s new office in New York City represents a strategic effort to tap into the shifting marketing gravity centre for global brands, which recently moved from European headquarters to the U.S.

Industry Leaders Trust Kainjoo in Regulated Industries.

Kainjoo Inc. has built a reputation for excellence and is trusted by leading companies such as Ferring Pharmaceuticals, Thermo Fisher, Abbott, and Medtronic. It has served US customers since its opening in 2012. These clients have recognized Kainjoo’s unique ability to navigate complex regulatory landscapes and deliver impactful advertising strategies tailored to their needs. For example, Kainjoo’s work with Abbott has involved developing targeted marketing campaigns that adhere to strict healthcare regulations, ensuring compliance while maximizing reach and engagement. “Kainjoo’s innovative approach has significantly improved our outreach while maintaining compliance with healthcare standards,” said Haider Alleg, Founder of Kainjoo and General Partner at Allegory Capital.

Kainjoo will be managing Allegory Capital’s $50M 2k32 Fund

Kainjoo is the management company for Allegory Capital’s $50M 2k32 fund, designed to support regulated industries acquiring or investing in tech ventures. This strategic initiative underscores Kainjoo’s dedication to fostering innovation and growth within its client base. Allegory Capital aims to bridge the gap between regulated industries and technological advancements, providing the financial support to drive digital transformation. For instance, by managing Allegory Capital, Kainjoo can help healthcare companies invest in new technologies that improve patient care and streamline operations. “The collaboration with Kainjoo through Allegory Capital has enabled us to explore and integrate cutting-edge solutions that enhance our service delivery,” said Haider Alleg.